LPS inmobilization on porous and non-porous supports as an approach for the isolation of anti-LPS host-defense peptides

Frontiers in Microbiology

Volumn 4, Issue DEC, 2013, Pages

  López Abarrategui, Carlos ^a   del Monte Martínez, Alberto ^a   Reyes Acosta, Osvaldo ^b   Franco, Octavio L ^c   Otero González, Anselmo J ^a  

^a UNIVERSITY OF HAVANA   (Cuba)

^b CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^c UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

Author keywords

Affinity chromatography; Antiendotoxic; Antimicrobial peptides; LPS; LPS immobilization

Indexed keywords

ALPHA CASEIN; ALPHA DEFENSIN; AMINOCAPROIC ACID; AMYLOID A PROTEIN; BETA CASEIN; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD14 ANTIGEN; CYANOGEN BROMIDE; ENDOTOXIN; ENDOTOXIN ANTIBODY; GLYOXAL; KAPPA CASEIN; LACTOFERRIN; LIPID A; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; NEUTRALIZING ANTIBODY; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN MD 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

AFFINITY CHROMATOGRAPHY; ANTIBACTERIAL ACTIVITY; BINDING AFFINITY; GRAM NEGATIVE BACTERIUM; GROWTH INHIBITION; HOST RESISTANCE; HUMAN; IMMOBILIZATION; IMMUNE RESPONSE; INNATE IMMUNITY; LIMULUS LYSATE TEST; MACROPHAGE; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; REVIEW; SEPTIC SHOCK;

EID: 84892167084     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2013.00389     Document Type: Review

References (73)

1. Adib-Conquy, M., and Cavaillon, J. M. (2012). [Host inflammatory and anti-inflammatory response during sepsis]. Pathol. Biol. (Paris) 60, 306-313. doi: 10.1016/j.patbio.2012.03.011.
2. Andra, J., Gutsmann, T., Garidel, P., and Brandenburg, K. (2006). Mechanisms of endotoxin neutralization by synthetic cationic compounds. J. Endotoxin. Res. 12, 261-277. doi: 10.1179/096805106X118852.
3. Andra, J., Lohner, K., Blondelle, S. E., Jerala, R., Moriyon, I., Koch, M. H., et al. (2005). Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide. Biochem. J. 385, 135-143. doi: 10.1042/BJ20041270.
4. Beamer, L. J., Carroll, S. F., and Eisenberg, D. (1997). Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 276, 1861-1864. doi: 10.1126/science.276.5320.1861.
5. Bhattacharjya, S. (2010). De novo designed lipopolysaccharide binding peptides: structure based development of antiendotoxic and antimicrobial drugs. Curr. Med. Chem. 17, 3080-3093. doi: 10.2174/092986710791959756.
6. Bhattacharjya, S., Domadia, P. N., Bhunia, A., Malladi, S., and David, S. A. (2007). High-resolution solution structure of a designed peptide bound to lipopolysaccharide: transferred nuclear Overhauser effects, micelle selectivity, and anti-endotoxic activity. Biochemistry 46, 5864-5874. doi: 10.1021/bi6025159.
7. Bhunia, A., Mohanram, H., and Bhattacharjya, S. (2009). Lipopolysaccharide bound structures of the active fragments of fowlicidin-1, a cathelicidin family of antimicrobial and antiendotoxic peptide from chicken, determined by transferred nuclear Overhauser effect spectroscopy. Biopolymers 92, 9-22. doi: 10.1002/bip.21104.
8. Bowdish, D. M., and Hancock, R. E. (2005). Anti-endotoxin properties of cationic host defense peptides and proteins. J. Endotoxin. Res. 11, 230-236. doi: 10.1179/096805105X37394.
9. Brandenburg, K., Schromm, A. B., and Gutsmann, T. (2010). Endotoxins: relationship between structure, function, and activity. Subcell. Biochem. 53, 53-67. doi: 10.1007/978-90-481-9078-2_3.
10. Bryant, C. E., Spring, D. R., Gangloff, M., and Gay, N. J. (2010). The molecular basis of the host response to lipopolysaccharide. Nat. Rev. Microbiol. 8, 8-14. doi: 10.1038/nrmicro2266.
11. Buttenschoen, K., Radermacher, P., and Bracht, H. (2010). Endotoxin elimination in sepsis: physiology and therapeutic application. Langenbecks Arch. Surg. 395, 597-605. doi: 10.1007/s00423-010-0658-6.
12. Cao, Y., Yu, R. Q., Liu, Y., Zhou, H. X., Song, L. L., Cao, Y., et al. (2010). Design, recombinant expression, and antibacterial activity of the cecropins-melittin hybrid antimicrobial peptides. Curr. Microbiol. 61, 169-175. doi: 10.1007/s00284-010-9592-7.
13. Chiou, S. T., Chen, Y. W., Chen, S. C., Chao, C. F., and Liu, T. Y. (2000). Isolation and characterization of proteins that bind to galactose, lipopolysaccharide of Escherichia coli, and protein A of Staphylococcus aureus from the hemolymph of Tachypleus tridentatus. J. Biol. Chem. 275, 1630-1634. doi: 10.1074/jbc.275.3.1630.
14. De Kimpe, S. J., Kengatharan, M., Thiemermann, C., and Vane, J. R. (1995). The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. U.S.A. 92, 10359-10363. doi: 10.1073/pnas.92.22.10359.
15. Ding, J. L., Li, P., and Ho, B. (2008). The sushi peptides: structural characterization and mode of action against Gram-negative bacteria. Cell. Mol. Life Sci. 65, 1202-1219. doi: 10.1007/s00018-008-7456-0.
16. Domingues, M. M., Santos, N. C., and Castanho, M. A. (2012). Antimicrobial peptide rBPI21: a translational overview from bench to clinical studies. Curr. Protein Pept. Sci. 13, 611-619. doi: 10.2174/1389203711209070611.
17. Eller, K., Henkes, E., Rossbacher, R., and Höke, H. (2000). "Amines, Aliphatic," in Ullmann's Encyclopedia of Industrial Chemistry (Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA).
18. Fornara, A., Johansson, P., Petersson, K., Gustafsson, S., Qin, J., Olsson, E., et al. (2008). Tailored magnetic nanoparticles for direct and sensitive detection of biomolecules in biological samples. Nano Lett. 8, 3423-3428. doi: 10.1021/nl8022498.
19. Genfa, L., Jiang, Z., Hong, Z., Yimin, Z., Liangxi, W., Guo, W., et al. (2005). The screening and isolation of an effective anti-endotoxin monomer from Radix Paeoniae Rubra using affinity biosensor technology. Int. Immunopharmacol. 5, 1007-1017. doi: 10.1016/j.intimp.2005.01.013.
20. Giacometti, A., Cirioni, O., Ghiselli, R., Mocchegiani, F., Orlando, F., Silvestri, C., et al. (2006). Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. Antimicrob. Agents Chemother. 50, 2478-2486. doi: 10.1128/AAC.01553-05.
21. Giuliani, A., Pirri, G., and Rinaldi, A. C. (2010). Antimicrobial peptides: the LPS connection. Methods Mol. Biol. 618, 137-154. doi: 10.1007/978-1-60761-594-1_10.
22. Gustafsson, A., Olin, A. I., and Ljunggren, L. (2010). LPS interactions with immobilized and soluble antimicrobial peptides. Scand. J. Clin. Lab. Invest. 70, 194-200. doi: 10.3109/00365511003663622.
23. Gustavsson, P. E., and Larsson, P. O. (2006). "Support materials for affinity chromatography," in Handbook of Affinity Immobilization, ed. D.S. Hage (Boca Raton: CRC press/Taylor and Francis Group), 15-34.
24. Hale, J. D., and Hancock, R. E. (2007). Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti. Infect. Ther. 5, 951-959. doi: 10.1586/14787210.5.6.951.
25. Hoess, A., Watson, S., Siber, G. R., and Liddington, R. (1993). Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. EMBO J. 12, 3351-3356.
26. Horak, D., Babic, M., Mackova, H., and Benes, M. J. (2007). Preparation and properties of magnetic nano-and microsized particles for biological and environmental separations. J. Sep. Sci. 30, 1751-1772. doi: 10.1002/jssc.200700088.
27. Jacks, T. J., De Lucca, A. J., and Brogden, K. A. (1996). Interaction of lipopolysaccharide with the antimicrobial peptide "cecropin A". Adv. Exp. Med. Biol. 391, 357-360. doi: 10.1007/978-1-4613-0361-9_29.
28. Jenssen, H., Hamill, P., and Hancock, R. E. (2006). Peptide antimicrobial agents. Clin. Microbiol. Rev. 19, 491-511. doi: 10.1128/CMR.00056-05.
29. Kaconis, Y., Kowalski, I., Howe, J., Brauser, A., Richter, W., Razquin-Olazaran, I., et al. (2011). Biophysical mechanisms of endotoxin neutralization by cationic amphiphilic peptides. Biophys. J. 100, 2652-2661. doi: 10.1016/j.bpj.2011.04.041.
30. Kalle, M., Papareddy, P., Kasetty, G., Morgelin, M., Van Der Plas, M. J., Rydengard, V., et al. (2012). Host defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsis. PLoS ONE 7:e51313. doi: 10.1371/journal.pone.0051313.
31. Kotsaki, A., and Giamarellos-Bourboulis, E. J. (2012). Emerging drugs for the treatment of sepsis. Expert Opin. Emerg. Drugs 17, 379-391. doi: 10.1517/14728214.2012.697151.
32. Koyama, Y., Motobu, M., Hikosaka, K., Yamada, M., Nakamura, K., Saido-Sakanaka, H., et al. (2006). Protective effects of antimicrobial peptides derived from the beetle Allomyrina dichotoma defensin on endotoxic shock in mice. Int. Immunopharmacol. 6, 234-240. doi: 10.1016/j.intimp.2005.08.008.
33. Lee, S. H., Jun, H. K., Lee, H. R., Chung, C. P., and Choi, B. K. (2010). Antibacterial and lipopolysaccharide (LPS)-neutralizing activity of human cationic antimicrobial peptides against periodontopathogens. Int. J. Antimicrob. Agents 35, 138-145. doi: 10.1016/j.ijantimicag.2009.09.024.
34. Li, D., Liu, Y., Yang, Y., Chen, J. H., Yang, J., Zou, L. Y., et al. (2013). Looped host defense peptide CLP-19 binds to microtubules and inhibits surface expression of TLR4 on mouse macrophages. J. Immunol. doi: 10.4049/jimmunol.1203167.
35. Lin, M. C., Pan, C. Y., Hui, C. F., Chen, J. Y., and Wu, J. L. (2013). Shrimp anti-lipopolysaccharide factor (SALF), an antimicrobial peptide, inhibits proinflammatory cytokine expressions through the MAPK and NF-kappaB pathways in LPS-induced HeLa cells. Peptides 40, 42-48. doi: 10.1016/j.peptides.2012.11.010.
36. Liu, H., Yu, H., Gu, Y., Xin, A., Zhang, Y., Diao, H., et al. (2013). Human beta-defensin DEFB126 is capable of inhibiting LPS-mediated inflammation. Appl. Microbiol. Biotechnol. 97, 3395-3408. doi: 10.1007/s00253-012-4588-9.
37. Mcgettrick, A. F., and O'Neill, L. A. (2010). Regulators of TLR4 signaling by endotoxins. Subcell. Biochem. 53, 153-171. doi: 10.1007/978-90-481-9078-2_7.
38. Miller, S. I., Ernst, R. K., and Bader, M. W. (2005). LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3, 36-46. doi: 10.1038/nrmicro1068.
39. Minetti, C. A., Lin, Y. A., Cislo, T., and Liu, T. Y. (1991). Purification and characterization of an endotoxin-binding protein with protease inhibitory activity from Limulus amebocytes. J. Biol. Chem. 266, 20773-20780.
40. Mookherjee, N., Lippert, D. N., Hamill, P., Falsafi, R., Nijnik, A., Kindrachuk, J., et al. (2009). Intracellular receptor for human host defense peptide LL-37 in monocytes. J. Immunol. 183, 2688-2696. doi: 10.4049/jimmunol.0802586.
41. Motzkus, D., Schulz-Maronde, S., Heitland, A., Schulz, A., Forssmann, W. G., Jubner, M., et al. (2006). The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo. FASEB J. 20, 1701-1702. doi: 10.1096/fj.05-4970fje.
42. Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., et al. (2002). Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin. Diagn. Lab. Immunol. 9, 972-982. doi: 10.1128/CDLI.9.5.972-982.2002.
43. Nell, M. J., Tjabringa, G. S., Wafelman, A. R., Verrijk, R., Hiemstra, P. S., Drijfhout, J. W., et al. (2005). Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 27, 649-660. doi: 10.1016/j.peptides.2005.09.016.
44. O'Shannessy, D. J., and Wilchek, M. (1990). Immobilization of glycoconjugates by their oligosaccharides: use of hydrazido-derivatized matrices. Anal. Biochem. 191, 1-8. doi: 10.1016/0003-2697(90)90377-L.
45. Pallarola, D., and Battaglini, F. (2008). An efficient method for conjugation of a lipopolysaccharide from Salmonella enterica sv. Minnesota with probes bearing hydrazine or amino functional groups. Anal. Biochem. 381, 53-58. doi: 10.1016/j.ab.2008.06.008.
46. Pallarola, D., and Battaglini, F. (2009). Surfactant-assisted lipopolysaccharide conjugation employing a cyanopyridinium agent and its application to a competitive assay. Anal. Chem. 81, 3824-3829. doi: 10.1021/ac9001639.
47. Park, S. C., Park, Y., and Hahm, K. S. (2011). The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int. J. Mol. Sci. 12, 5971-5992. doi: 10.3390/ijms12095971.
48. Piazza, M., Colombo, M., Zanoni, I., Granucci, F., Tortora, P., Weiss, J., et al. (2011). Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling. Angew. Chem. Int. Ed. Engl. 50, 622-626. doi: 10.1002/anie.201004655.
49. Pristovsek, P., and Kidric, J. (1999). Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study. J. Med. Chem. 42, 4604-4613. doi: 10.1021/jm991031b.
50. Pristovsek, P., and Kidric, J. (2001). Peptides neutralizing lipopolysaccharide-structure and function. Mini Rev. Med. Chem. 1, 409-416. doi: 10.2174/1389557013406729.
51. Pulido, D., Nogues, M. V., Boix, E., and Torrent, M. (2012). Lipopolysaccharide neutralization by antimicrobial peptides: a gambit in the innate host defense strategy. J. Innate Immun. 4, 327-336. doi: 10.1159/000336713.
52. Ruberto, F., Ianni, S., Babetto, C., Magnanimi, E., Ferretti, G., Novelli, G., et al. (2013). Polymyxin-B endotoxin removal device: making the point on mechanisms of action, clinical effectiveness and possible future applications: review. Infect. Disord. Drug Targets 13, 128-132. doi: 10.2174/18715265113139990025.
53. Saido-Sakanaka, H., Ishibashi, J., Momotani, E., Amano, F., and Yamakawa, M. (2004). In vitro and in vivo activity of antimicrobial peptides synthesized based on the insect defensin. Peptides 25, 19-27. doi: 10.1016/j.peptides.2003.12.009.
54. Salomao, R., Brunialti, M. K., Rapozo, M. M., Baggio-Zappia, G. L., Galanos, C., and Freudenberg, M. (2012). Bacterial sensing, cell signaling, and modulation of the immune response during sepsis. Shock 38, 227-242. doi: 10.1097/SHK.0b013e318262c4b0.
55. Sawyer, J. G., Martin, N. L., and Hancock, R. E. (1988). Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect. Immun. 56, 693-698.
56. Schadich, E., Mason, D., and Cole, A. L. (2013). Neutralization of bacterial endotoxins by frog antimicrobial peptides. Microbiol. Immunol. 57, 159-161. doi: 10.1111/1348-0421.12012.
57. Schulte, W., Bernhagen, J., and Bucala, R. (2013). Cytokines in sepsis: potent immunoregulators and potential therapeutic targets-an updated view. Mediators Inflamm. 2013:165974. doi: 10.1155/2013/165974.
58. Scott, A., Weldon, S., Buchanan, P. J., Schock, B., Ernst, R. K., Mcauley, D. F., et al. (2011). Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. PLoS ONE 6:e26525. doi: 10.1371/journal.pone.0026525.
59. Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., and Hancock, R. E. (2002). The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169, 3883-3891.
60. Scott, M. G., Vreugdenhil, A. C., Buurman, W. A., Hancock, R. E., and Gold, M. R. (2000). Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J. Immunol. 164, 549-553.
61. Shahriar, F., Gordon, J. R., and Simko, E. (2006). Identification of lipopolysaccharide-binding proteins in porcine milk. Can. J. Vet. Res. 70, 243-250.
62. Silipo, A., and Molinaro, A. (2011). "Lipid A structure," in Bacterial Lipopolysaccharides: Structure, Chemical Synthesis, Biogenesis and Interaction with Host Cells, eds Y.A. Knirel and M.A. Valvano (New York: Springer-Verlag/Wien), 1-20.
63. Singh, S., Papareddy, P., Kalle, M., Schmidtchen, A., and Malmsten, M. (2013). Importance of lipopolysaccharide aggregate disruption for the anti-endotoxic effects of heparin cofactor II peptides. Biochim. Biophys. Acta 1828, 2709-2719. doi:10.1016/j.bbamem.2013.06.015.
64. Tack, B. F., Sawai, M. V., Kearney, W. R., Robertson, A. D., Sherman, M. A., Wang, W., et al. (2002). SMAP-29 has two LPS-binding sites and a central hinge. Eur. J. Biochem. 269, 1181-1189. doi: 10.1046/j.0014-2956.2002.02751.x.
65. Tan, N. S., Ng, M. L., Yau, Y. H., Chong, P. K., Ho, B., and Ding, J. L. (2000). Definition of endotoxin binding sites in horseshoe crab factor C recombinant sushi proteins and neutralization of endotoxin by sushi peptides. FASEB J. 14, 1801-1813. doi: 10.1096/fj.99-0866com.
66. Tossi, A., Scocchi, M., Skerlavaj, B., and Gennaro, R. (1994). Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes. FEBS Lett. 339, 108-112. doi: 10.1016/0014-5793(94)80395-1.
67. Urh, M., Simpson, D., and Zhao, K. (2009). Affinity chromatography: general methods. Methods Enzymol. 463, 417-438. doi: 10.1016/S0076-6879(09)63026-3.
68. Vaara, M. (2009). New approaches in peptide antibiotics. Curr. Opin. Pharmacol. 9, 571-576. doi: 10.1016/j.coph.2009.08.002.
69. Wieczorek, M., Jenssen, H., Kindrachuk, J., Scott, W. R., Elliott, M., Hilpert, K., et al. (2010). Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem. Biol. 17, 970-980. doi: 10.1016/j.chembiol.2010.07.007.
70. Yu, H., Dong, J., Gu, Y., Liu, H., Xin, A., Shi, H., et al. (2013). The novel human beta-defensin 114 regulates lipopolysaccharide (LPS)-mediated inflammation and protects sperm from motility loss. J. Biol. Chem. 288, 12270-12282. doi: 10.1074/jbc.M112.411884.
71. Yu, L., Tan, M., Ho, B., Ding, J. L., and Wohland, T. (2006). Determination of critical micelle concentrations and aggregation numbers by fluorescence correlation spectroscopy: aggregation of a lipopolysaccharide. Anal. Chim. Acta 556, 216-225. doi: 10.1016/j.aca.2005.09.008.
72. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415, 389-395. doi: 10.1038/415389a.
73. Zheng, X., Yang, D., Liu, X., Wang, N., Li, B., Cao, H., et al. (2010). Identification of a new anti-LPS agent, geniposide, from Gardenia jasminoides Ellis, and its ability of direct binding and neutralization of lipopolysaccharide in vitro and in vivo. Int. Immunopharmacol. 10, 1209-1219. doi: 10.1016/j.intimp.2010.07.001.